Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

Parallel Session 3412

Alpha-Synuclein as a Therapeutic Target

Tuesday, August 29, 2023
15:00 – 17:00


In this session, the faculty will give an overview on fundamental physiological underpinnings of DBS from animal work to computational methods; present clinical criteria for patient selection and discuss current translational developments of DBS optimization for clinical practice.

Taku Hatano, Japan 
Tiago Outeiro, Germany

Biology Update
Poul Henning Jensen, Denmark 

Ayami Okuzumi, Japan 

Lowering and Preventing the Spread
Wassilios Meissner, France 

CSPC Liaison: 
Tiago Outeiro, Germany

At the conclusion of this session, participants should be better able to:

  1. Discuss our current understanding of the biological function of a-synuclein and how it is pathologically related with synucleinopathies
  2. Recognize the value of a-synuclein as a biomarker in Parkinson’s disease and other synucleinopathies
  3. Assess the status of therapeutic strategies aimed at lowering and preventing the spread of a-synuclein pathology

Recommended Audience:
Clinician, Researcher / Basic Scientist, Health Professional (non-physician), Fellow / Resident / Student, Industry

Education Level:
Beginner/Foundational, Intermediate/Experienced, Advanced/Expert

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice